Paris, France and Camberley, UK – 26 January 2021 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that it was notified on 26 January 2021 that, as at 25 January 2021 BlackRock Inc.’s holding in the Company on a voting and capital basis is 3.02% (2,132,372 shares).
http://novacyt.com/wp-content/uploads/2021/01/Novacyt-BlackRock-holdings-26.01.2021-ENGLISH.pdf